These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

286 related articles for article (PubMed ID: 9141800)

  • 1. Hemostatic profile in nephrotic syndrome.
    Anand NK; Chand G; Talib VH; Chellani H; Pande J
    Indian Pediatr; 1996 Dec; 33(12):1005-12. PubMed ID: 9141800
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hemostatic problems and thromboembolic complications in nephrotic children.
    Citak A; Emre S; Sâirin A; Bilge I; Nayir A
    Pediatr Nephrol; 2000 Feb; 14(2):138-42. PubMed ID: 10684364
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protein C and protein S in pediatric nephrotic patients.
    Yermiahu T; Shalev H; Landau D; Dvilansky A
    Sangre (Barc); 1996 Apr; 41(2):155-7. PubMed ID: 9045358
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Natural coagulation inhibitors; antithrombin III, protein C, protein S in children with hypercoagulation due to nephrotic syndrome].
    Wygledowska G; Grygalewicz J; Matuszewska E
    Med Wieku Rozwoj; 2001; 5(4):377-88. PubMed ID: 12004145
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Haemostatic parameters in childhood nephrotic syndrome. (Is there any difference in protein C levels between steroid sensitive and resistant groups?).
    Yalçinkaya F; Tümer N; Gorgani AN; Ekim M; Cakar N
    Int Urol Nephrol; 1995; 27(5):643-7. PubMed ID: 8775051
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Antithrombin III in infantile nephrotic syndrome].
    Lorusso L; Miniello VL; Francioso G; Aceto G; DiBitonto G; Penza R
    Boll Soc Ital Biol Sper; 1982 Sep; 58(17):1093. PubMed ID: 7138678
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hemorheological and hemostatic parameters in children with nephrotic syndrome undergoing steroid therapy.
    André E; Voisin P; André JL; Briquel ME; Stoltz JF; Martinet N; Alexandre P
    Nephron; 1994; 68(2):184-91. PubMed ID: 7830855
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nephrotic syndrome resulting in thromboembolic disease and disseminated intravascular coagulation in a dog.
    Ritt MG; Rogers KS; Thomas JS
    J Am Anim Hosp Assoc; 1997; 33(5):385-91. PubMed ID: 9278113
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protein C and D-dimer are related to portal vein thrombosis in patients with liver cirrhosis.
    Zhang D; Hao J; Yang N
    J Gastroenterol Hepatol; 2010 Jan; 25(1):116-21. PubMed ID: 19686413
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antithrombin III level in children with nephrotic syndrome, its correlation to thromboembolic complications, and serum albumin level.
    Hussein SK; Mohammed AH; Mohammed RA; Abdelghafar H
    Saudi J Kidney Dis Transpl; 2021; 32(5):1283-1288. PubMed ID: 35532697
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Coagulation and fibrinolysis proteins in nephrotic syndromes in children].
    Loirat C; Pillion G; Schlegel N; Douenias R; Mathieu H
    Arch Fr Pediatr; 1979 Nov; 36(9 Suppl):LVI-LXIII. PubMed ID: 539878
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fresh frozen plasma has no beneficial effect on the hemostatic system in children receiving L-asparaginase.
    Halton JM; Mitchell LG; Vegh P; Eves M; Andrew ME
    Am J Hematol; 1994 Nov; 47(3):157-61. PubMed ID: 7524313
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Concentration of tissue plasminogen activator and its inhibitor 1 in cyclosporine A-treated children with idiopathic nephrotic syndrome].
    Tkaczyk M; Owczarek D; Finke D; Nowicki M
    Pol Merkur Lekarski; 2003 Apr; 14(82):315-8. PubMed ID: 12868191
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of coagulation parameters in the early period after kidney transplantation.
    Pawlicki J; Cierpka L; Król R; Ziaja J
    Transplant Proc; 2007 Nov; 39(9):2754-5. PubMed ID: 18021978
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Incidence and clinical significance of thromboses and thrombo-embolic complications in nephrotic syndrome patients].
    Kuhlmann U; Steurer J; Bollinger A; Pouliadis G; Briner J; Siegenthaler W
    Schweiz Med Wochenschr; 1981 Jul; 111(27-28):1034-40. PubMed ID: 7268357
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Coagulation factors in nephrotic syndrome.
    Kanfer A
    Am J Nephrol; 1990; 10 Suppl 1():63-8. PubMed ID: 2256477
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nonvalvular atrial fibrillation: evidence for a prothrombotic state.
    Kahn SR; Solymoss S; Flegel KM
    CMAJ; 1997 Sep; 157(6):673-81. PubMed ID: 9307553
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thalassemia major-- on the verge of bleeding or thrombosis?
    Naithani R; Chandra J; Narayan S; Sharma S; Singh V
    Hematology; 2006 Feb; 11(1):57-61. PubMed ID: 16522552
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tissue factor pathway inhibitor in childhood nephrotic syndrome.
    Al-Mugeiren MM; Abdel Gader AG; Al-Rasheed SA; Al-Salloum AA
    Pediatr Nephrol; 2006 Jun; 21(6):771-7. PubMed ID: 16575589
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High serum adiponectin levels during steroid-responsive nephrotic syndrome relapse.
    Bakkaloglu SA; Soylemezoglu O; Buyan N; Funahashi T; Elhan AH; Peru H; Fidan K; Yilmaz S; Hasanoglu E
    Pediatr Nephrol; 2005 Apr; 20(4):474-7. PubMed ID: 15690190
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.